176548-72-4

Basic information

• Product Name: 3-FLUORO-5-METHOXYBENZOIC ACID 98
• Synonyms: 3-FLUORO-5-METHOXYBENZOIC ACID 98;3-Fluoro-5-methoxybenzoic acid 98%
• CAS NO: 176548-72-4
• Molecular Formula: C₈H₇FO₃
• Molecular Weight: 170.1383
• Product Categories: blocks;Carboxes;FluoroCompounds
• Mol File: 176548-72-4.mol

Chemical Properties

• Melting Point: 130-133
• Boiling Point: 278.4±20.0℃ (760 Torr)
• Flash Point: 122.2±21.8℃
• Appearance: /
• Density: 1.307±0.06 g/cm3 (20 ºC 760 Torr)
• Storage Temp.: Keep Cold
• PKA: 3.74±0.10(Predicted)
• CAS DataBase Reference: 3-FLUORO-5-METHOXYBENZOIC ACID 98(CAS DataBase Reference)
• NIST Chemistry Reference: 3-FLUORO-5-METHOXYBENZOIC ACID 98(176548-72-4)
• EPA Substance Registry System: 3-FLUORO-5-METHOXYBENZOIC ACID 98(176548-72-4)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 176548-72-4(Hazardous Substances Data)

Usage

Uses

Used in Chemical Synthesis:
3-Fluoro-5-methoxybenzoic acid 98 is used as an intermediate in organic synthesis for the production of various chemical compounds. Its unique structure, with fluorine and methoxy groups, allows for specific reactivity that can be exploited in the synthesis of target molecules.
Used in Pharmaceutical Industry:
3-Fluoro-5-methoxybenzoic acid 98 is used as a building block in the development of pharmaceutical compounds. Its chemical properties and reactivity make it a valuable component in the synthesis of new drugs, potentially leading to the discovery of novel therapeutic agents.
Used in Material Science:
3-Fluoro-5-methoxybenzoic acid 98 is used as a precursor in the synthesis of advanced materials, such as polymers and coatings, that may exhibit unique properties due to the presence of fluorine and methoxy groups. These materials can be utilized in various applications, including electronics, automotive, and aerospace industries.

Upstream product

• 455-40-3 3,5-difluorobenzoic acid 
• 124-41-4 sodium methylate 
• 439280-18-9 3-Fluoro-5-methoxybenzonitrile 

Downstream Products

• 176548-87-1 1-(3-fluoro-5-methoxyphenyl)ethanone 
• 1509919-76-9 ethyl 3-(3-fluoro-5-methoxybenzamido)furo[2,3-b]pyridine-2-carboxylate 
• 1509919-69-0 3-fluoro-5-[4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenol 
• 1509919-97-4 2-(3-fluoro-5-methoxyphenyl)-4-(morpholin-4-yl)pyrido[3',2':4,5]furo[3,2-d]pyrimidine 
• 1509919-90-7 2-(3-fluoro-5-methoxyphenyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-4(3H)-one 
• 1509919-83-8 3-(3-fluoro-5-methoxybenzamido)furo[2,3-b]pyridine-2-carboxamide 
• 1352306-24-1 1-(2,5-dimethoxyphenyl)-2-(3-fluoro-5-methoxyphenyl)ethanone 
• 914637-33-5 2-(3-fluoro-5-methoxyphenyl)acetic acid 
• 914637-27-7 (3-fluoro-5-methoxyphenyl)methanol 
• 1214346-07-2 1-(chloromethyl)-3-fluoro-5-methoxybenzene 
• 914637-31-3 2-(3-fluoro-5-methoxyphenyl)acetonitrile 
• 1276670-02-0 3-fluoro-5-methoxy-N-(4-(3-(trifluoromethyl)phenylsulfonyl)cyclohexyl)benzamide 
• 453567-38-9 3-(5-Fluoro-pyridin-2-yl)-5-(3-fluoro-5-methoxyphenyl)-1,2,4-oxadiazole 
• 1092789-19-9 3-fluoro-5-methoxybenzoyl chloride 

Relevant articles and documents

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.

Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease

The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.

NOVEL COMPOUNDS

The invention relates to substituted phenylacetic acids as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.